Skip to main content
. 2018 Jun 13;118(12):1665–1671. doi: 10.1038/s41416-018-0106-x

Table 3.

Risk of obesity-related cancer according to combined effect of weight change and MetDys

Weight changea/MetDys N PY Cases I/1000 py HR (95% CI)b
All subjects
  Weight loss or weight stable/no MetDys 2131 33,908 161 4.75 1.00
  Weight gain/no MetDys 1040 15,219 85 5.59 1.31 (1.00, 1.71)
  Weight loss or weight stable/MetDys 384 5623 32 5.69 1.21 (0.83, 1.78)
  Weight gain/MetDys 295 3962 32 8.08 1.77 (1.21, 2.59)
Men
  Weight loss or weight stable/no MetDys 1047 16,716 66 3.95 1.00
  Weight gain/no MetDys 385 5681 22 3.87 1.15 (0.71, 1.87)
  Weight loss or weight stable/MetDys 266 3767 20 5.31 1.25 (0.76, 2.08)
  Weight gain/MetDys 145 1887 12 6.36 1.85 (1.00, 3.44)
Women
  Weight loss or stability/no MetDys 1084 17,192 95 5.53 1.00
 Weight gain/no MetDys 655 9537 63 6.61 1.34 (0.97, 1.85)
  Weight loss or stability/MetDys 118 1856 12 6.47 1.09 (0.60, 1.99)
  Weight gain/MetDys 150 2075 20 9.64 1.74 (1.07, 2.82)

CI confidence interval, HR hazards ratio, I/1000 py incidence of cancer cases per 1000 person-years, MetDys metabolic dysfunction.

aWeight loss =  loss of 0.45 kg or more per year, weight gain = gain of 0.45 kg or more per year; weight stable = loss or gain of <0.45 kg/year.

bAdjusted for sex (for all subjects model), age, average adult height, education, cigarettes per day, alcohol intake and physical activity